Hugh Rosen, M.D., Ph.D
Professor of Molecular Medicine, Scripps Research Institute
With over 30 years of experience, Dr. Rosen's research has focused on lymphocyte trafficking. His work at The Scripp’s Research Institute led to the development of Ozanimod, a drug which helps alleviate brain atrophy for patients with multiple sclerosis, among other medications.
April 3, 2020
COVID-19 Epicenters
As coronavirus continues to spread across New York City, other virus hot spots are emerging across the country, including Detroit and New Orleans. These epicenters are seeing a surge in coronavirus patients but lack the medic...
March 27, 2020
COVID-19 Treatments
Both the federal and state governments have begun turning to the private sector for solutions to supply tests, masks, and other necessary materials for fighting COVID-19. The private sector may also have potential coronavirus...